Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5510_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
76 Мб
Скачать
12  •  Oral Potentially Malignant Disorders and Oral Cancer
193
of PVL sufferers develop oral cancer and progressive increase in dysplasia grade is frequently seen in sequential biopsies. Close follow-up is undertaken as the mucosal lesions are often too large to permit laser excision and the aim is to detect oral cancer as early as possible. Sometimes multifocal synchro­nous and nonsynchronous oral cancers occur.
Exophytic Verrucous Hyperplasia
This is a recently recognized disorder described by an expert group in Southeast Asia. It is characterized by verrucous or papillary growth, sometimes on a background of submu­cous fibrosis that lacks any downward growth of the hyper­plasic oral epithelium. The natural history is uncertain and there may be overlap with PVL and other verrucous muco­sal lesions. Patients with exophytic verrucous hyperplasia should be regarded as having an oral potentially malignant disorder until larger studies become available

ORAL SUBMUCOUS FIBROSIS

Oral submucous fibrosis is related to using paan, which is a leaf quid containing areca nut. Many types exist, including fresh products consumed in the Indian subcontinent and Southeast Asia, as well as packed proprietary products. Tobacco, slaked lime, spices and other ingredients may be added; in Southeast Asia, areca nuts are often chewed fresh. The mucosa and teeth become stained orange–brown be­cause paan is held in the mouth for long periods. The affected mucosa becomes pale in colour and feels firm on palpation (Fig. 12.2). Fibrous bands may develop in the buc­cal mucosa and a pale, constricting fibrosis typically involves the palate. Mouth opening becomes restricted and swallow­ing may be difficult. The risk of developing oral carcinoma has been estimated at around 5%, although the risk of sub­mucous fibrosis itself cannot be separated from the risks posed by carcinogenic substances in paan. In biopsy mate­rial, a subepithelial band of fine fibrillary collagen is seen in the lamina propria and the oral epithelium can be reduced to only a few cell layers in thickness. Keratinisation and chronic inflammation may be present in some cases. Where areas of erythroplakia and leukoplakia are present, biopsies may show epithelial dysplasia or even carcinoma.

PALATAL LESIONS IN REVERSE SMOKERS

Reverse smoking is prevalent in countries such as Sri Lanka, Venezuela, Sardinia, Panama and India, particularly in the state of Andhra Pradesh. The smoker puts the lit end of a type of cheroot into the oral cavity, then inhales the smoke from the burning end. Palatal lesions are consequently common and are known to undergo malignant transforma­tion over time.

GENETIC MUCOSAL LESIONS

The rare disorders tylosis, epidermolysis bullosa and dys­keratosis congenita predispose to the development of OP­MDs and oral cancer. Keratotic and red lesions may also be found in Fanconi’s anaemia and these are known to have a high transformation rate to oral cancer. Patients with these disorders should be followed up at least 6 month intervals.

CLINICALLY NORMAL SUSCEPTIBLE MUCOSA

It is recognized that in certain conditions the oral mucosa has increased susceptibility to oral cancer even if no clinical abnormality can be observed in the oral cavity. The oral mucosa in such instances is therefore considered as an OPMD. Chronic iron deficiency results in generalised muco­sal atrophy because iron is an essential growth requirement for the oral epithelium. Sideropenic dysphagia is a known risk factor for oral cancer but can be mitigated by treating medically. Genetic disorders (as mentioned in the previous section) such as Fanconi’s anaemia may also have a phase where the oral mucosa is clinically normal, though visible lesions may develop during surveillance.

12.2 Pathology, Dysplasia Grading and Management

LEARNING OBJECTIVES
You should:
• know the features of epithelial dysplasia.
• understand the significance of dysplasia grade.
• be aware of the biology and molecular pathology of
OPMDs.
Fig. 12.2 Submucous fibrosis showing tethering bands involving the buccal mucosa.

EPITHELIAL DYSPLASIA

The term dysplasia is used in a variety of contexts in pathol­ogy and means literally ‘abnormal growth’. In the context of OPMDs, it refers to a combination of cytological changes and disturbances of cellular arrangements seen during the process of malignant transformation. Epithelial dysplasia is currently categorized by oral and maxillofacial pathologists into mild, moderate and severe grades (Figs. 12.3 and
12.4). An alternative binary grading system that classifies
‘low grade’ and ‘high grade’ dysplasia may be used. Such binary systems are widely used in pathology for potentially malignant disorders in sites other than the oral cavity. The architectural and cellular features seen in dysplasia are given in Table 12.2.
194
Master Dentistry
Fig. 12.3 Mild epithelial dysplasia, with subtle cytological atypia
Fig. 12.4 Moderate epithelial dysplasia, some oral pathologists might
grade this as severe epithelial dysplasia, but would agree that it is a high-grade dysplasia.
Table 12.2 Microscopic Features of Epithelial Dysplasia
HISTOLOGICAL ARCHITECTURAL FEATURES SIGNIFICANCE
Irregular epithelial stratification Keratinisation may be seen in the lower layers of oral epithelium; orderly maturation is disturbed
Loss of polarity of basal cells Loss of the intrinsic symmetry in the shape, structure and organisation of basal cells.
Drop shaped rete processes Basal cell proliferation and accumulation alter the interface morphology
Increased number of mitotic figures Molecular changes to oncogenes, tumour suppressor genes and transcriptional factors drive
Abnormally superficial mitotic figures Mitotic figures are normally seen in basally located stem cells and their amplifying progeny. Arrested
Premature keratinisation in single cells (dyskeratosis)
Keratin pearls within rete processes Keratinisation in concentric layers of cells results in a whorl or keratin pearl; this can be a reactive
Loss of epithelial cell cohesion Loss of intercellular cohesion between keratinocytes (acantholysis) causes cell separation and round-
HISTOLOGICAL CELLULAR FEATURES SIGNIFICANCE
Anisonucleosis Abnormal variation in nuclear size resulting from abnormal nuclear structural and activity
Nuclear pleomorphism Abnormal variation in nuclear shape resulting from changes in nuclear structure and activity
Anisoscytosis Abnormal variation in cell size
Cellular pleomorphism Abnormal variation is cell shape Keratinocytes may become spindle-shaped in HPV-related dysplasia
Increased nuclear to cytoplasmic ration Often results from increased nuclear size and dysregulation of nuclear and cytoplasmic processes
Atypical mitotic figures Atypical mitotic figures have an abnormal chromosomal distribution or an excessive number
Increased number and size of nucleoli Nucleoli are the sites of ribosome biogenesis and their increase may reflect greater protein
Nuclear hyperchromasia Dark staining by haematoxylin may be the result of increased nuclear DNA content
FEATURES SEEN IN CYTOLOGY PREPARATIONS SIGNIFICANCE
Nuclear changes Clumping and irregular distribution of chromatin, nuclear crowding, irregularities of nuclear
Image analysis of nuclear features DNA ploidy is a powerful predictor of malignant transformation
Cytoplasmic changes Keratinisation, tadpole-shaped, spindle-shaped and bizarre cytoplasmic outlines
Alteration of basal-apical polarity may be a cause of tumour initiation and may reflect early epithelial-mesenchymal transition
increased cell proliferation
mitotic figures (mitosoid bodies) are seen in the superficial layers in HPV-related dysplasia
Dyskeratosis is caused by premature keratin formation resulting in compacted eosinophilic cytoplasm and change in cell shape in the lower cell layers
feature
ing of shape. It is a feature of some immune-mediated and inflammatory diseases as well as dysplasia
changes impacting on chromatin packing
of mitotic spindles resulting in multipolar appearance
synthesis; however, abnormality of their many other functions may be important drivers of dysplasia
membrane, micronuclei and nuclear moulding may be seen in addition to nuclear features observed in histological sections
HPV, Human papilloma virus.
Grading of Dysplasia
Studies on histopathological grading show poor agree­ment between even specialist pathologists. This problem arises partly because of lack of scientific evidence for weighting the various features of dysplasia. For example, drop-shaped rete processes are generally accepted as a sin­ister feature, whereas increased mitotic rate may be seen in reactive processes. Both inter- and intraobserver variability rates are high and the biological behaviour of an individ­ual OPMD does not always correlate with its grade. A meta-analysis study showed that mild (low grade) dyspla­sia was associated with an annual malignant transforma­tion rate of 1.7%, whereas combined moderate and severe (high grade) dysplasia had a 3.7% annual transformation rate. Problems with grading may also arise because of nonrepresentative sampling at the time of biopsy. It is im­portant to select the area of greatest clinical suspicion for biopsy of an OPMD and sometimes multiple punch biopsies can reveal where the most florid changes are present. In contrast to biopsy of a suspected oral cancer, there is no requirement to include the margin with normal tissue. Although histopathological grading is intrinsically unreli­able, the presence of dysplasia in a suspicious lesion re­mains the best-known predictive indicator of malignant change.
12  •  Oral Potentially Malignant Disorders and Oral Cancer
Fig. 12.5 Human papilloma virus (HPV)–related dysplasia, showing mitosoid bodies high in the epithelium and disordered maturation.
195
differentiated lesions that are low risk. Further research is required, and it is likely that a combination of biomarkers will come into clinical use in the future. Clinical assessment by experienced specialists remains the gold standard for the diagnosis and management of OPMDs currently.

MOLECULAR PATHOLOGY OF OPMDS

A complex pattern of accumulation of gene mutations and transcriptional dysregulation leads to transformation from normal tissue to a cancer. Large scale sequencing studies have shown that OMPDs show similar molecular changes to those found in oral cancer, but with lower mu­tational rates. The most frequent mutations in OMPDs are found in TP53, CDKN2A, NOTCH1 and PIK3CA, though numerous other genes are known to be mutated but at much lower frequency. The mutational burden increases with progression of dysplasia grade and is highest in oral cancer. Commonly, T.C substitutions in the sequence context 59-ATN-39 correlate with tobacco exposure. Alterations in mRNA transcripts have also been found and may have predictive value when combined into a molecu­lar signature.
High-risk HPV has been found in a subset of OMPDs clinically diagnosed as leukoplakia, erythroleukoplakia or erythroplakia, most often occurring in the floor of the mouth or ventral tongue. Severe dysplasia with charac­teristic histological features, including intraepithelial spindle cells and mitosoid bodies, is found and the diagno­sis can be confirmed by HPV testing (Fig. 12.5). Malig­nant transformation has been described in HPV-related dysplasia, but more evidence is needed to determine whether it behaves differently from its non-HPV–related counterparts.
Biomarkers have been extensively researched to aid in risk stratification of OPMDs. Ploidy analysis can detect rela­tively gross changes to DNA and is a useful tool that can supplement dysplasia grading. It can be difficult to recog­nize early dysplasia where minimal changes are present and only hyperkeratosis is seen in the biopsy. Immunohisto­chemical staining for cytokeratin 13 can be used to identify

12.3 Management of OPMDs

Clinical risk factors for malignant change include tobacco habit, high alcohol intake and possibly poor diet. Clinical factors that must also be taken into account are:
n
female gender
n
extensive or spreading lesions
n
lesions in the floor of mouth/ventral tongue, retromolar area, palate or pillar of fauces
n
red, speckled, verrucous or nodular appearance
n
presence of multifocal lesions.
Most important is the presence of epithelial dysplasia. Management should include:
n
clear information and explanation of the significance of the lesion to the patient
n
intervention to stop tobacco habit, paan use and limit alcohol intake
n
treat anaemia, Candida infection or other underlying factors if present
n
surgical or laser excision or drug treatment may be considered
n
regular review and observation, and intraoral photogra­phy can be useful
n
prompt investigation if signs or symptoms of cancer appear.
Referral to a specialist centre is usually advisable for pa­tients presenting with white or red mucosal patches, or other suspicious lesions. Biopsy is normally required for di­agnosis and to determine whether epithelial dysplasia is present. Occasionally biopsy may show invasive cancer in a white or red patch at the outset. Patients with OMPDs may be followed up in primary or secondary care settings or through shared care pathways.
196
Master Dentistry

12.4 Oral Cancers

LEARNING OBJECTIVES
You should:
• know the global epidemiology and types of oral cancers.
• know the clinical and pathological features of squamous
cell carcinoma,
• understand the principles of management of squamous
cell carcinoma,
Most oral cancers do not arise in a clinically identified oral potentially malignant disorder and are diagnosed as primary cancerous lesions. They are typically painless, unless infected or advanced, and often cause no symptoms. For this reason, the need to conduct a careful systematic examination for every patient cannot be stressed too much. Extra-oral exami­nation should include both visual inspection of the face and neck and palpation of the neck (see Chapters 2 and 16). The patient’s head should be tilted forwards and the lymph nodes in the neck palpated in relaxed tissue. A routine technique should be adopted, perhaps starting with the submental nodes and then moving to more posterior node groups. The oral mucosa and oropharynx should be examined carefully. The tongue should be protruded to detect lateral deviation and then relaxed and lifted to allow examination of its ven­tral surface and the floor of the mouth. Correct positioning and the use of good illumination and mirrors are important factors. When oral cancer is detected, prompt referral is es­sential. The importance of attending at the hospital should be stressed, without provoking undue anxiety. Until a biopsy result is available, providing a definitive diagnosis should be avoided. Any ulcer that fails to heal within a 3-week period should be regarded as suspicious, and the patient should be referred to a specialist.

EPIDEMIOLOGY

Global Incidence and Trends
The global incidence of oral and oropharyngeal cancer has been estimated at over 400,000 new cases per year. The incidence of oral squamous carcinoma is 9 per 100,000 in the UK resulting in around 6800 new cases every year. There is marked geographical variation in distribution, with the highest incidence in the Indian subcontinent and Southeast Asia, because of the particular use of paan and tobacco. Oral cancer ranks in the top ten in the global prevalence tables of cancer. The incidence of oral cancer is rising and more cases are seen in younger age groups. The male to female ratio of around 2.5:1 is also changing, with an increasing oral cancer incidence in women, particularly involving the tongue.
Morbidity and Mortality
Overall, 5-year survival for oral cancer is just over 50% but depends very much on the stage at initial diagnosis and clinical factors. Squamous cell carcinoma of the lip has a better prognosis than intraoral carcinoma. In general, prognosis is worse when tumours arise in the more poste­rior parts of the oral cavity than in the anterior area. Mid­line carcinomas in the floor of the mouth and ventral
tongue may, however, spread to both sides of the neck. Staging is a system used to describe the degree of spread or tumour ‘load’ and the most widely used TNM (tumour, lymph node, metastases) system is described in Table 12.3. Survival at 5 years for TNM stage I oral carcinoma is around 80%, whereas survival is reduced to 15% for stage IV. Morbidity refers to a reduction in function, both physical and psychological. Again, morbidity tends to relate to stage, as large tumours may require removal of a large amount of tissue or radical radiotherapy, sometimes combined with
Table 12.3 Staging Using the TNM8 System
T—PRIMARY TUMOUR
T1 Tumour 2 cm or less in greatest dimension and 5 mm or less
depth of invasion
T2 Tumour 2 cm or less in greatest dimension and more than
5 mm but no more than 10 mm depth of invasion or tumour more than 2 cm but not more than 4 cm in greatest dimension and depth of invasion no more than 10 mm
T3 Tumour more than 4 cm in greatest dimension or more than
10 mm depth of invasion
T4a (Lip) Tumour invades through cortical bone, inferior alveolar
nerve, floor of mouth or skin (of the nose or chin)
T4a (Oral cavity) Tumour invades through cortical bone of the
mandible or involves the maxillary sinus, or invades the skin of the face
T4b (Lip and oral cavity) Tumour invades the masticator space,
pterygoid plates, or skull base, or encases internal carotid artery
N—REGIONAL LYMPH NODES
N0 No regional lymph node metastasis
N1 Metastasis in a single ipsilateral lymph node, 3 cm or less in
greatest dimension without extranodal extension
N2a Metastasis in a single ipsilateral lymph node, more than 3 cm
but less than 6 cm in greatest dimension, without extranodal extension
N2b Metastasis in multiple ipsilateral lymph nodes, none more
than 6 cm in greatest dimension, without extranodal extension
N2c Metastasis in bilateral or contralateral lymph nodes, none
more than 6 cm in greatest dimension, without extranodal extension
N3a Metastasis in a lymph node more than 6 cm in greatest
dimension without extranodal extension
N3b Metastasis in a single or multiple lymph nodes with clinical
extranodal extension
M—DISTANT METASTASIS
M0 No distant metastases
M1 Distant metastases
STAGE GROUPING
Stage I T1 N0 M0
Stage II T2 N0 M0
Stage III T3 N0 M0
T1, T2, T3 N1 M0
Stage IVA T4a N0, N1 M0
T1, T2, T3, T4a N2 M0
Stage IVB Any T N3 M0
T4b Any N M0
Stage IVC Any T Any N M1
chemotherapy and neck dissection. Hospital re-admission is frequent during treatment and, in many cases, tumours prove refractory to all forms of therapy. Quality of life can be assessed and is an important measure of morbidity. Good dental health is a significant factor.

TYPES OF ORAL CANCER

Squamous cell carcinoma accounts for around 95% of all oral cancers. It arises from the epithelial lining of the oral cavity. It is described in detail in the next section. A num­ber of other forms of malignant disease also arise in the oral cavity.
12  •  Oral Potentially Malignant Disorders and Oral Cancer
197

MINOR SALIVARY GLAND CANCERS

These tend to occur in the palate and upper lip and they present as rubbery nodules, sometimes ulcerated and pain­ful. They are described in Chapter 14.

MALIGNANT MELANOMA

This typically occurs in the palatal and gingival mucosa. A spreading, brown-pigmented patch or a raised ulcer­ated nodule, surrounded by pigmented mucosa, may be seen (Fig. 12.6). Prognosis is poor in nodular malignant melanoma.

MALIGNANT LYMPHOMA

Extranodal lymphoma arises principally in the oropharynx in the area of Waldeyer’s ring including the soft palate, base of tongue and tonsils. Nodular infiltration of the mucosa is seen and lymph nodes in the neck may become involved.

LEUKAEMIA

Leukaemia may present with oral signs such as persistent gingival haemorrhage and oral ulceration. Acute myeloid leukaemia and childhood leukaemia may cause gingival enlargement because of direct infiltration of leukaemic cells (Fig. 12.7).
Fig. 12.7 Generalised gingival enlargement caused by acute leukaemia.

METASTATIC DEPOSITS

Metastasis from primary cancers in the kidney, gastrointes­tinal tract, lung, breast, prostate and other sites occur in the oral cavity. Deposits of metastatic tumour often present as gingival nodules or as destructive bone lesions. Metastatic lesions in the jaws are usually radiolucent, but prostate and some breast metastases appear as sclerotic lesions in bone.

RARE NEOPLASMS

Malignant primary soft tissue and bone tumours can arise in the oral cavity and jaws. Odontogenic malignant tumours are known but are very rare.

SQUAMOUS CELL CARCINOMA

Aetiology
Smoking
Cigarette smoking is the most important aetiological factor for intra-oral cancer in the Western world. Risk increases with cumulative dose, which is measured in ‘pack-years’. There are no safe levels. The risk is greatest when combined with high alcohol intake. It is believed that carcinogens in tobacco smoke accumulate in the floor of the mouth, ac­counting for the increased risk of squamous carcinoma at that site.
Fig. 12.6 Malignant melanoma of the palate.
Paan and Other Tobacco Use
Paan, also known as betel quid, is used throughout the In­dian subcontinent. Leaf of the betel piper vine is used to form a rolled-up quid, into which areca nut is placed. Areca is thought to contain alkaloid carcinogenic precursors. In addition, tobacco, spices and slaked lime may be added. The quid is held in the oral cavity for a considerable time and is habit-forming. Buccal and labial cancers are commonly as­sociated with paan use. Other tobacco habits exist, includ­ing smearing tobacco paste into the mouth and reverse smoking, which has been linked to palatal cancer. In recent times, areca nut has become popular in Southeast Asia.
Alcohol
Alcohol is a cause of oral cancer and is an important co ­factor when combined with smoking. Acetaldehydes which
198
Master Dentistry
cause DNA damage are produced by metabolism of alcohol. In the oral cavity, alcohol may directly increase epithelial permeability, allowing greater access of carcinogenic sub­stances to the basal cells. The oral cancer risk is similar with all forms of alcoholic drink and other chemicals in the bev­erage called congeners are thought to add to the risk, par­ticularly in certain home distilled products.
Ultraviolet Light
Ultraviolet B is an important factor in lip cancer. Fair­skinned races in tropical latitudes are particularly at risk from sunlight. Protection, using measures such as sun block and wearing a wide-brimmed hat, is advocated where there is high risk.
Diet
Evidence is accumulating that a poor diet with low anti­oxidant action (deficient in fresh vegetable content) is an important contributory factor.
Viruses
HPV is an important factor in oropharyngeal cancer and is thought to drive the increasing incidence in men despite falling smoking rates. Oropharyngeal carcinoma arises mostly in the tonsil, soft palate and base of the tongue and is thought to originate from the reticular epithelium in the folds of the lymphoid tissue. In contrast, HPV-related oral cavity cancer is very rare and routine testing for HPV is not undertaken on mouth cancers. Some authors have sug­gested a possible viral aetiology for oral cancer in those cases where no risk factors are identified. No viral se­quences have been identified to date in that group although the immune signature in such cases suggests that a virus may have triggered early changes and then been cleared.
Clinical Features
The Lip
Although the lip is the most common site for oral cancer, in­traoral cases are detected more often by dentists. The lower lip is almost exclusively affected, often to one side of the mid­line (Fig. 12.8). Shallow ulceration, crusting or thickening are typical presentations. Spread to the submental nodes
tends to be slow; if detected early, this cancer has the best prognosis.
Intra-oral Surfaces
The floor of the mouth, ventral tongue and lateral anterior tongue are most commonly involved. All too frequently, in­traoral cancer is symptomless and reaches an advanced stage before detection. The classical description is of a hard, fixed ulcer, with raised rolled margins and a necrotic base (Fig. 12.9). It is vital to remember that squamous carcino­mas may also present as white or red mucosal patches, fleshy polyps, punched-out ulcers, indurated plaques or by tethering mucosa. The tongue may become fixed to the floor of the mouth, making it difficult for the patient to raise it. Alternatively, the tongue may deviate to the side of an oropharyngeal tumour on protrusion (Fig. 12.10). Some­times patients present with nodal metastasis in the neck from an occult primary lesion, particularly from the oro­pharynx. Nodal deposits of metastatic squamous carci­noma in the neck are tested for HPV and Epstein-Barr virus (EBV, indicating likely origin from the oropharynx or nasopharynx, respectively).
Squamous cell carcinoma also arises on the gingivae, al­veolar ridge, buccal mucosa and palate, albeit less commonly (Fig. 12.11). Bone invasion is an early feature of carcinoma arising in mucoperiosteum and extension through the cortex to invade marrow spaces is an adverse feature
Head and Neck
Dentists should also be aware of extra-oral cancers. Basal cell carcinomas, squamous cell carcinomas and malignant melanomas are common on the facial skin (Chapter 13). Squamous cell carcinoma arises in the maxillary sinus (Chapter 7), nasopharynx (where is often associated with EBV) and larynx. Persistent hoarse voice can be a present­ing sign of laryngeal cancer and should trigger referral to an otolaryngologist.
Pathology
Histopathological Features
Microscopically, squamous cell carcinoma comprises sheets of squamous epithelial cells supported by a fibrous stroma
Fig. 12.8 An early squamous cell carcinoma on the lower lip.
Fig. 12.9 A squamous cell carcinoma of the floor of the mouth show-
ing the typical raised rolled borders. The lesion was painless and the patient presented requesting new dentures.
12  •  Oral Potentially Malignant Disorders and Oral Cancer
Fig. 12.12 The margin of a squamous cell carcinoma, the normal mar­gin is on the right side and islands of atypical squamous cells can be seen invading the connective tissue on the left of the photograph.
199
Fig. 12.10 Tongue deviation on thrusting. This patient had an oro-
pharyngeal cancer on the left side that tethered the tongue causing deviation to the left.
Fig. 12.11 A gingival squamous cell carcinoma.
containing the tumour vasculature. The squamous cells can be recognised by their tendency to form flattened layers held together by prominent intracellular bridges (desmo­somes). Often, individual cells undergo keratinisation and the most conspicuous feature is the formation of keratin pearls or whorls (Figs. 12.12 and 12.13). The vast majority
Fig. 12.13 Squamous cell carcinoma showing a keratin pearl and cyto­logical atypia.
of tumours are moderately differentiated, though examples of well-differentiated and poorly differentiated carcinomas occur. Increased mitotic activity is seen and bizarre mitotic figures are often present. Nuclear and cellular pleomor­phism and nuclear hyperchromatism are typical features. Necrosis is present in some cases due to tumour cell growth outstripping nutritional supply and is usually associated with poor prognosis driven by chronic hypoxia. A key fea­ture is invasion of the adjacent tissues by detachment and movement of the carcinoma cells. Invasion may be on a cohesive front or a diffuse non-cohesive front (Fig. 12.14). Carcinoma spreads along anatomical planes. Adverse his­tological features that are recognised are spread along nerves (perineural invasion), vascular channels (lympho­vascular invasion) or into the sarcolemmal sheaths of mus­cle fibres (Figs. 12.15 and 12.16). A chronic inflammatory response is usually seen at the invasive front. Many carcino­mas are thought to arise in a wide field of mucosal change. Second primary cancers can arise at the same time
200
Master Dentistry
Fig. 12.14 Invasive margin of a squamous cell carcinoma showing small groups and individual cells in the connective tissue. This is a noncohesive invasive pattern indicating an adverse prognosis.
(synchronous) or more than 6 months later than the pre­senting cancer (metachronous) and are a significant cause of poor outcome. Over a 15-year span, around 25% of patients may develop a second primary cancer.
When an incisional biopsy is undertaken on clinically suspicious mucosal lesions, it is important to include the margin of the ulcer. The biopsy must be of sufficient depth and crush damage must be avoided. Failure to sample appropriately may lead to misdiagnosis.
Bone Invasion
In addition to local spread into soft tissues, oral squamous cell carcinoma can spread into adjacent bone. At first the periosteum acts as a barrier but cortical resorption can lead to entry of the carcinoma cells to marrow spaces and bone destruction. Radiographs show irregular bone destruction and teeth may be displaced or resorbed. Contrast enhanced computed tomography (CT), and magnetic resonance im­aging (MRI) scanning are used in combination to deter­mine the extent of bone and soft tissue spread (Figs. 12.17 and 12.18). Spread of squamous carcinoma through the bone cortex to invade the medullary cavity is an adverse histological finding (Fig. 12.19).
Fig. 12.15 Lymphovascular invasion. A cord of carcinoma may grow in the lumen of a lymphatic vessel.
Fig 12.16 Neural invasion. Groups of atypical squamous cells surround the nerve sheath and are seen here infiltrating between the nerve fibres.
Metastasis
Carcinoma spreads to regional lymph nodes via the lym­phatics. The primary site is important: lip cancers spread to the submental nodes, whereas intra-oral tumours are more likely to spread to the cervical nodes (see Chapter 2,
Fig. 2.1). Involved lymph nodes become first palpable and
then fixed and hard. With increasing tumour growth, nodes may become cystic as a result of central necrosis or even matted together to form a craggy mass. Spread of the neoplastic cells outside the lymph node capsule is known as extranodal extension and is a powerful predictor of ad­verse outcome (Fig. 12.20). Tumours in the anterior floor of the mouth and tongue may metastasise to both sides of the neck. Imaging can also identify suspicious nodal me­tastasis to help treatment planning. Fine-needle aspira­tion and core biopsies can be used to detect cancer in equivocal nodes.
Distant metastasis is a relatively late event but spread may occur to the lungs, brain, viscera and bone. Chest radi­ography, isotopic bone scans and whole-body CT or PET may be used to detect distant metastasis.
Grading and Staging
Histological Grading: Prognostic Features
Histological grading refers to those features seen in the microscope that can be related to the biological behaviour of the tumour. The degree of differentiation is not a par­ticularly good indicator of prognosis in oral squamous cell carcinoma. Pattern of invasion is more important; tumours that invade tissue on a noncohesive front (single cells or narrow strands) have a worse prognosis than those that invade on a broad front. Perineural and lym­phovascular invasion are also indicators of poor progno­sis. As yet, no molecular markers are in routine use for prediction of outcome or to guide therapy in oral cancer. As described above, markers for high-risk HPV are manda­tory for oropharyngeal carcinomas where HPV signals a more favourable prognosis.
12  •  Oral Potentially Malignant Disorders and Oral Cancer
201
A B
Fig. 12.17 A buccal squamous cell carcinoma shown by (A) CT and (B) contrast-enhanced MRI scans invading and destroying the right maxillary tuberosity.
A B
Fig. 12.18 (A) and (B). MRI scanning is used here to map the extent of a primary squamous cell carcinoma arising from the retromolar trigone.
Staging: TNM Classification
Clinical and pathological staging refers to determination of the extent of tumour size and spread. The patient is exam­ined carefully and imaging is used to aid in the detection of involved neck nodes. The TNM (Table 12.3) system is widely used. Pathological staging (pTNM) is undertaken on surgi­cally resected specimens and is more accurate than clinical staging. Pathologists record detailed information on the neck dissection, including the levels containing lymph nodes involved by metastatic disease (Fig. 12.21).
Imaging of Oral Squamous Cell Carcinoma
The role of imaging in oral cancer management includes:
n
identifying tumour size and anatomical extent
n
detection of regional nodes (staging)
n
detection of distant metastases
n
post-treatment follow-up.
Plain radiographs have a very limited role to play in assess­ment and management of oral squamous cell carcinoma. Advanced lesions on the floor of the mouth may cause gross
202
Master Dentistry
Fig. 12.19 Bone invasion by carcinoma. The tumour is seen top right and it stimulates osteoclasts to erode the bone surfaces, leaving scal­loped outlines.
Fig. 12.21 The levels of the neck agreed by consensus used for record­ing staging as part of the dataset for neck dissections.
Fig. 12.20 A lymph node from the neck containing a deposit of meta­static squamous cell carcinoma from an oral primary lesion. Note that there is florid extracapsular spread with neoplastic cells extending into adjacent fibro-adipose tissue. Extra-nodal extension is the most power­ful predictor of adverse outcome in neck metastatic disease.
bone destruction in the adjacent mandible, but detection of early bony involvement has poor sensitivity. CT using bone windows provides a good diagnostic sensitivity for detection of bone involvement. Panoramic radiographs are useful for preoperative assessment of patients who require dental inter­ventions prior to receiving radiotherapy.
Imaging of oral squamous cell carcinoma relies upon cross-sectional techniques (i.e., CT or MRI). Thin-slice (3–5-mm) CT sections are usually performed through the oral region and neck. Intravenous iodinated contrast is given and the scans are repeated, because neoplastic lesions of the floor of the mouth and tongue base tend to enhance, which improves the delineation between normal and ab­normal tissues. Contrast also highlights vessels, allowing them to be more easily distinguished from nodes. PET can be used to detect small deposits of metastatic carcinoma
and can often localise ‘unknown’ primary sites. However, MRI scanning is often the best at defining the leading edge and margins of a primary carcinoma within soft tissue, es­pecially if that tissue also enhances with contrast, for ex­ample the tonsils. In addition, specific sequences of MRI enable early detection of perineural spread, not possible with other imaging modalities. Unfortunately, bone changes are not as easily evaluated on MRI as on CT, and the longer scan time presents a risk of patient movement which will spoil the imaging.
When examining images of submandibular and jugu­lodigastric nodes of the internal jugular chain, those nodes with a diameter exceeding 1.5 cm are abnormal; in other parts of the neck, 1 cm is the maximum size of normal nodes. A low-density centre in nodes of normal shape is most likely to represent the adipose tissue of the hilum and may be found in normal, hyperplastic and inflamed nodes. Central enhancement of a lymph node is suggestive of metastatic tumour. When lymph nodes appear enlarged, round and possess a low density centre, the combination of features is typical of tumour necrosis and indicates meta­static disease. Imaging can provide an indication of extra­capsular extension of the tumour. In addition, imaging contributes to the clinical staging process not least because it shows deeply situated nodes (e.g., retropharyngeal, hilar and pretracheal) beyond the scope of clinical (or endoscopic) examination.
Treatment
The treatment of oral cancer is usually surgery. The patient is normally discussed at a multidisciplinary team meeting (MDTM) where the margin clearance, any adverse histo­logical findings and patient factors such as the patients views and comorbidities are considered. Surgery may be followed by adjunctive radiotherapy, sometimes combined